Tarsus Pharmaceuticals, Inc. — Institutional Ownership

Which tracked institutions hold TARS, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.

30
Funds holding
$882663952
Total value held
Buying
23 added/new · 7 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Blackrock, Inc. $242705264 3856137 +303525 +8.54%
2 Janus Henderson Group Plc $157222823 2240963 +2240963 NEW BUY
3 Morgan Stanley $114996594 1827082 -117190 -6.03%
4 Bank Of America Corp /De/ $75098874 1193182 -1195 -0.10%
5 State Street Corp $67531536 1072951 +94739 +9.68%
6 Invesco Ltd. $49458755 785808 +785808 NEW BUY
7 Goldman Sachs Group Inc $46745097 742693 +303067 +68.94%
8 Toronto Dominion Bank $35073504 557253 +47000 +9.21%
9 Northern Trust Corp $24333296 386611 +33654 +9.53%
10 Franklin Resources Inc $18001343 286008 -47668 -14.29%
11 Jpmorgan Chase & Co $8683850 139981 +109503 +359.29%
12 Jefferies Financial Group Inc. $7477901 118810 +118810 NEW BUY
13 Bank Of New York Mellon Corp $7203966 114458 +7676 +7.19%
14 Wells Fargo & Company/Mn $7026559 111639 +22346 +25.03%
15 Ubs Group Ag $4627852 73528 +73528 NEW BUY
16 Citigroup Inc $4235736 67298 +15327 +29.49%
17 Federated Hermes, Inc. $4097143 65096 +65096 NEW BUY
18 Barclays Plc $2307253 36658 +8654 +30.90%
19 Raymond James Financial Inc $1884739 29945 -4839 -13.91%
20 Sei Investments Co $1563576 24843 -6232 -20.05%
21 Stifel Financial Corp $588927 9357 +9357 NEW BUY
22 Ameriprise Financial Inc $535494 8508 +8508 NEW BUY
23 Prudential Financial Inc $436174 6930 +705 +11.33%
24 Fifth Third Bancorp $327388 5201 +278 +5.65%
25 Royal Bank Of Canada $263000 4190 +1230 +41.55%
26 Principal Financial Group Inc $201534 3202 +347 +12.15%
27 Pnc Financial Services Group, Inc. $30338 482 -228 -32.11%
28 Zions Bancorporation, National Association /Ut/ $3651 58 +58 NEW BUY
29 Us Bancorp \De\ $1763 28 -26 -48.15%
30 Amalgamated Financial Corp. $22 1306 +1306 NEW BUY

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.